Applied Evidence

Strategies to identify and prevent penicillin allergy mislabeling and appropriately de-label patients

Author and Disclosure Information

 

References

De-labeling requires a systems approach. Given the mismatch between the large number of patients labeled “penicillin allergic” and the few allergy specialists, referral alone is not enough to solve the problem of mislabeling. Targeting specific populations for testing, such as patients presenting to an inner-city sexually transmitted infection clinic19 or preoperative patients, as is done at the Mayo Clinic,9 has been successful. Skin testing in an inpatient setting has also been shown to be safe and effective,13 allowing for protocol-driven testing under the supervision of trained pharmacists (and others), to relieve the burden on allergy specialists.9

CORRESPONDENCE
Andrew Lutzkanin, MD, 500 University Drive, PO Box 850, Hershey, PA 17033; alutzkanin@pennstatehealth.psu.edu

Pages

Recommended Reading

Bifidobacteria supplementation regulates newborn immune system
MDedge Family Medicine
The challenge of poverty to health and success: What should pediatricians do?
MDedge Family Medicine
There’s a much safer food allergy immunotherapy – why don’t more doctors offer it?
MDedge Family Medicine
Direct-care allergy clinic specializes in sublingual immunotherapy
MDedge Family Medicine
Sublingual immunotherapy: Where does it stand?
MDedge Family Medicine
No link between childhood vaccinations and allergies or asthma
MDedge Family Medicine
Summer campers spread COVID at home, follow-up finds
MDedge Family Medicine
Exposure to marijuana smoke linked to increased risk of respiratory infections in children
MDedge Family Medicine
Peanut allergy patients reap continuing benefits past first year, Palforzia study shows
MDedge Family Medicine
Emerging data point to underlying autoimmunity in ME/CFS
MDedge Family Medicine